European Union - English - EMA (European Medicines Agency)

krka, d.d., novo mesto - pramipexole dihydrochloride monohydrate - parkinson disease - anti-parkinson drugs - oprymea is indicated for treatment of the signs and symptoms of idiopathic parkinson's disease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on off" fluctuations).oprymea is indicated in adults for symptomatic treatment of moderate to severe idiopathic restless legs syndrome in doses up to 0.54 mg of base (0.75 mg of salt) (see section 4.2).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 260microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 1.57mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 2.1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 520microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 1.05mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 3.15mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - pramipexole dihydrochloride monohydrate - modified-release tablet - 2.62mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - pramipexole dihydrochloride monohydrate - tablet - 88microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - pramipexole dihydrochloride monohydrate - tablet - 180microgram